Paul G. Gabos

Paul G. Gabos, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lincare Holdings Inc, Pediatrix Medical Group, Inc. and Benefytt Technologies, Inc. The record holds 74 filings, for trades running from 4 April 2007 to 12 May 2021.

On the open market, the record shows 7 purchases worth €1.1M and 18 sales worth €32.2M. Sales outweigh purchases by €31.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 21 share grants and 23 option exercises.

Half of the purchases are above €91k and half below.

The latest filing, published on 14 May 2021, reports a share grant in Pediatrix Medical Group, Inc. The clock since the last published purchase (10 April 2019) now reads 2,754 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.